NASDAQ: GANX - Gain Therapeutics, Inc.

Lønnsomhet i seks måneder: +47.28%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Gain Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, researches and develops novel therapies to treat diseases caused by protein misfolding in Switzerland and Spain. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. Its lead product candidate includes GT-02287, for the treatment of GBA1 Parkinson's disease.

flere detaljer
In addition, the company is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. Gain Therapeutics, Inc. was founded in 2017 and is headquartered in Bethesda, Maryland.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-03-18
ISIN US36269B1052
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.gaintherapeutics.com
Цена ао 3.8
Prisendring per dag: +10% (1.6)
Prisendring per uke: +12.82% (1.56)
Prisendring per måned: +1.15% (1.74)
Prisendring over 3 måneder: -11.56% (1.99)
Prisendring over seks måneder: +47.28% (1.195)
Prisendring per år: -46.09% (3.265)
Prisendring over 3 år: -67.88% (5.48)
Prisendring over 5 år: 0% (1.76)
Prisendring over 10 år: 0% (1.76)
Prisendring siden begynnelsen av året: +2.33% (1.72)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 631.94 1
P/BV 2.77 6
P/E 0 0
EV/EBITDA -1.09 0
Total: 3.5

Effektivitet

Navn Betydning Karakter
ROA, % -119.66 0
ROE, % -177.03 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0359 10
Total: 8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 34.59 5
Lønnsomhet Ebitda, % 1008.48 10
Lønnsomhet EPS, % 357.22 10
Total: 9
Flere detaljer

Institusjoner Volum Dele, %
Greenlight Capital, Inc. 588410 3.63
Royal Bank of Canada 200248 1.23
Geode Capital Management, LLC 151476 0.93
CM Management, LLC 90000 0.55
Vanguard Group Inc 88385 0.54
Citadel Advisors Llc 65394 0.4
Prelude Capital Management LLC 58100 0.36
Bridgeway Capital Management, Inc. 46100 0.28
Northern Trust Corporation 43513 0.27
Renaissance Technologies, LLC 42800 0.26

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.00615 17.09 1.54048



Veileder Stillingstittel Betaling Fødselsår
Dr. Khalid Islam Ph.D. Executive Chairman 75k 1955 (70 år)
Dr. Joanne Taylor Ph.D. Senior Vice President of Research N/A
Dr. Terenzio Ignoni Pharm.D. Senior Vice President of Technical Operations N/A
Mr. Gene Mack M.B.A. CFO & Interim CEO N/A
Dr. Jonas Hannestad M.D., Ph.D. Chief Medical Officer N/A

Adresse: United States, Bethesda. MD, 4800 Montgomery Lane - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.gaintherapeutics.com